Find the Perfect Plan for Your Investment Journey
B
Latest price
52 Week Range
- - -
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | €53.31M |
EV | - |
Shares Outstanding | 24.57M |
Beta | 0.80 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | €2.80 |
P/E 2025E | - |
P/Revenue 2025E | 7.62x |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | 54.30% |
EPS | 46.90% |
Operating Cash Flow | 51.00% |
Free Cash Flow | 42.70% |
Gross Margin 2025E | - |
Net Profit Margin 2025E | -69.12% |
ROE 2025E | -63.10% |
ROCE 2024 | - |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
B
Bioretec Oy
BRETEC
Sector
Industry
CEO
Donze, Alan
Employees
Website
bioretec.comIPO Date
Headquarters
Yrittäjänkulma 5, Tampere, Pirkanmaa, 33710, Finland
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved